Keryx Biopharmaceuticals Fund Forecast

Keryx Biopharmaceuticals fund price down 0% on Thursday
(Updated on Dec 27, 2018)

KERX Signals & Forecast

The Keryx Biopharmaceuticals fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.36 and $3.08. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, December 12, 2018, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Keryx Biopharmaceuticals fund

Keryx Biopharmaceuticals finds support from accumulated volume at $3.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

The Keryx Biopharmaceuticals fund is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some funds may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the fund manages to break the trend before that occurs.

Our recommended stop-loss: $3.18 (-5.48%) (This fund has low daily movements and this gives low risk. The RSI14 is 76 and this increases the risk substantially. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (KERX) For The Upcoming Trading Day Of Friday 28th

For the upcoming trading day on Friday, 28th we expect Keryx Biopharmaceuticals to open at $3.36, and during the day (based on 14 day Average True Range), to move between $3.24 and $3.48, which gives a possible trading interval of +/-$0.119 (+/-3.55%) up or down from last closing price. If Keryx Biopharmaceuticals takes out the full calculated possible swing range there will be an estimated 7.09% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.40 (1.19%) than the support at $3.24 (3.57%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Keryx Biopharmaceuticals fund A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Keryx Biopharmaceuticals fund to perform well in the short-term.

Current score: 1.560 Buy Candidate Unchanged

Predicted Opening Price for Keryx Biopharmaceuticals of Friday, December 28, 2018

The predicted opening price is based on yesterday's movements between high, low, and closing price.